Business, energy, technology, markets and global industry news from Business News Today

supplements

PharmaDeviceNews supplements
Representative image: Niagen Bioscience’s investor conference push highlights the growing commercial debate around NAD+ science, healthy aging, Tru Niagen, Niagen Plus, and whether healthspan-focused platforms can convert clinical credibility into durable market confidence.
Pharma & Biotech

Why Niagen Bioscience’s next investor meetings could sharpen the NAD+ market debate

NAD+ is hot, but credibility is scarce. Niagen Bioscience now has to prove healthspan science can support durable investor trust.

Read More
Uqora broadens omnichannel reach with Target launch as women’s health shelves evolve
Pharma & Biotech

Can Uqora’s Target expansion turn urinary health into a mainstream wellness category?

Uqora has entered Target stores and Target.com. Find out what this expansion means for urinary health retail and women’s wellness growth.

Read More